ArticleResearch (Washington, D.C.)2025
Targeted-Modified MultiTransm Microelectrode Arrays Simultaneously Track Dopamine and Cellular Electrophysiology in Nucleus Accumbens during Sleep-Wake Transitions.
Article in Research (Washington, D.C.), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Multifunctional material platforms for neural interfaces: active orchestration of dynamic foreign body response across implantation lifetimes.Bioactive materials · 2026Review
- Acid Drop-Out in Carbon Capture and Transport Systems: Causes, Consequences, and Countermeasures.Materials (Basel, Switzerland) · 2026Review
- A Dual-Mode Wireless Microsystem for Monitoring Dopamine and Spike Changes with Dexmedetomidine.Cyborg and bionic systems (Washington, D.C.) · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
15 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cellular-level electrophysiological and neurotransmitter signals serve as key biomarkers of sleep depth, offering insights into the dynamic sleep transitions and the neural mechanisms underlying sleep regulation. Microelectrode arrays (MEAs) provide an innovative solution for in situ, simultaneous detection of these signals with high spatial and temporal resolution. However, despite substantial progress in electrode material development, current multimodal MEA systems remain fundamentally constrained by partial integration. This study aims to address the performance limitations of multimodal MEAs by developing a MultiTransm MEA (MT MEA), integrating a 3-electrode system with site-specific surface modifications: platinum nanoparticle (PtNP)/poly(3,4-ethylene dioxythiophene):poly(styrene sulfonate) (PEDOT:PSS)-modified sites for electrophysiology, PtNP/PEDOT:PSS/Nafion-modified sites for dopamine sensing, and iridium oxide (IrOx)-based on-probe reference electrodes. The directional surface modification strategy was employed to enable compact integration, minimize inter-channel crosstalk, preserve high spatiotemporal resolution for both electrophysiological and electrochemical detection, and ensure long-term operational stability. By incorporating electroencephalography (EEG) and electromyography (EMG), MT MEAs enable real-time in vivo monitoring of sleep dynamics within the nucleus accumbens. Three distinct spike types were identified, whose coordinated activity shaped the sleep architecture. In addition, EEG and local field potential (LFP) signals exhibited distinct patterns during wakefulness, indicating region-specific neural processing. Notably, dopamine release was lowest during non-rapid eye movement (NREM) sleep and peaked during wakefulness, suggesting a neuromodulatory role in sleep-wake transitions. These results demonstrate that MT MEAs are powerful tools for probing neural and neurochemical activity across sleep states, offering new insights into the physiological regulation of sleep.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.